UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[X] Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

For The Quarterly Period Ended: June 30, 2012

 

[ ] Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

For The Transition Period From ___________ to _______________

 

 

Commission File Number: 000-29621

 

XSUNX, INC.

(Exact name of registrant as specified in its charter)

 

Colorado		84-1384159
(State of incorporation)		(I.R.S. Employer Identification No.)

 

65 Enterprise, Aliso Viejo, CA 92656

(Address of principal executive offices) (Zip Code)

 

Registrant's telephone number: (949) 330-8060

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, during the preceding twelve (12) months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yesx No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

Large accelerated filer ¨

Accelerated filer ¨

Non-accelerated filer ¨

Smaller reporting company x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

 

The number of shares of common stock issued and outstanding as of August 14, 2012 was 279,807,224.

 

 

TABLE OF CONTENTS

 

		PAGE
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements		3
Balance Sheets June 30, 2012 (unaudited) and September 30, 2011 (audited)		3
Statements of Operations for the Three Months and Nine Months ended June 30, 2012 and 2011 (unaudited) and the period February 25, 1997 (inception) to June 30, 2012 (unaudited)		4
Statements of Stockholders Equity for the Nine Months ended June 30, 2012 (unaudited)		5
Statements of Cash Flows for the Nine Months ended June 30, 2012 and 2011 (unaudited) and the period February 27, 1997 (inception) to June 30, 2012 (unaudited)		6
Notes to Financial Statements (unaudited)		7
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations		15
Item 3 Qualitative and Quantitative Disclosures About Market Risk		18
Item 4. Controls and Procedures		18
PART II - OTHER INFORMATION
Item 1. Legal Proceedings		19
Item 1. A.Risk Factors		19
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		19
Item 3. Defaults upon Senior Securities		20
Item 4. (Removed and Reserved)		20
Item 5. Other Information		20
Item 6. Exhibits		21
Signatures		22

 

 

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements.

XSUNX, INC.

(A Development Stage Company)

BALANCE SHEETS

 

		June 30, 2012				September 30, 2011
		(Unaudited)
ASSETS
CURRENT ASSETS
Cash		$	56,571			$	66,576
Prepaid expenses			357,304				9,204
Total Current Assets			413,875				75,780
PROPERTY & EQUIPMENT
Office & miscellaneous equipment			29,841				29,841
Machinery & equipment			229,823				177,699
Leasehold improvements			23,511				—
			283,175				207,540
Less accumulated depreciation			(194,478	)			(164,472	)
Net Property & Equipment			88,697				43,068
OTHER ASSETS
Manufacturing equipment in progress			103,805				81,975
Security deposit			5,700				3,200
Total Other Assets			109,505				85,175
TOTAL ASSETS		$	612,077			$	204,023
LIABILITIES AND SHAREHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts payable		$	152,421			$	167,420
Accrued expenses			26,913				8,740
Credit card payable			646				1,099
Accrued interest on notes payable			26,726				95,641
Derivative liability			167,315				—
Convertible promissory notes, net of $89,371 in discounts			50,629				—
Unsecured promissory note			350,000				—
Note payable			—				456,921
Total Current Liabilities			774,650				729,821
TOTAL LIABILITIES			774,650				729,821
SHAREHOLDERS' DEFICIT
Preferred stock, $0.01 par value; 50,000,000 authorized preferred shares			—				—
Common stock, no par value; 500,000,000 authorized common shares 277,631,013 and 224,998,637 shares issued and outstanding, respectively			27,133,189				25,638,369
Additional paid in capital			5,331,848				5,238,213
Paid in capital, common stock warrants			3,764,913				3,635,079
Deficit accumulated during the development stage			(36,392,523	)			(35,037,459	)
TOTAL SHAREHOLDERS' DEFICIT			(162,573	)			(525,798	)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT		$	612,077			$	204,023

 

The accompanying notes are an integral part of these financial statements

XSUNX, INC.

(A Development Stage Company)

STATEMENTS OF OPERATIONS

(Unaudited)

 

																		From Inception
																		February 25, 1997
		Three Months Ended								Nine Months Ended								through
		June 30, 2012				June 30, 2011				June 30, 2012				June 30, 2011				June 30, 2012
REVENUE		$	—			$	—			$	—			$	—			$	14,880
OPERATING EXPENSES
Selling, general and administrative expenses			199,234				238,083				571,162				723,467				18,447,961
Research and development			35,506				47,423				95,476				222,029				3,259,430
Depreciation and amortization expense			12,182				9,660				30,006				29,098				717,832
TOTAL OPERATING EXPENSES			246,922				295,166				696,644				974,594				22,425,223
LOSS FROM OPERATIONS BEFORE  OTHER INCOME/(EXPENSES)			(246,922	)			(295,166	)			(696,644	)			(974,594	)			(22,410,343	)
OTHER INCOME/(EXPENSES)
Interest income			—				—				—				—				445,537
Gain/(Loss) on sale of asset			—				17,000				—				17,000				16,423
Impairment of assets			—				—				—				—				(7,285,120	)
Write down of inventory asset			—				—				—				—				(1,177,000	)
Gain on legal settlement			—				—				—				179,580				1,279,580
Loan and commitment fees			(45,000	)			—				(45,000	)			—				(7,046,990	)
Forgiveness of debt			—				—				—				—				592,154
Gain/(Loss) on conversion and settlement of debt			(283,939	)							(496,874	)			—				(496,874	)
Amortization of debt discount			(87,941	)			—				(146,129	)			—				(146,129	)
Gain/(Loss) on change in derivative			61,585				—				68,184				—				68,184
Other, non-operating			—				—				—				—				(5,215	)
Penalties			—								(22	)			—				(618	)
Interest expense			(15,709	)			(11,554	)			(38,579	)			(34,568	)			(226,111	)
TOTAL OTHER INCOME/(EXPENSES)			(371,004	)			5,446				(658,420	)			162,012				(13,982,179	)
NET LOSS		$	(617,926	)		$	(289,720	)		$	(1,355,064	)		$	(812,582	)		$	(36,392,522	)
BASIC AND DILUTED LOSS PER SHARE		$	(0.00	)		$	(0.00	)		$	(0.01	)		$	(0.00	)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING
BASIC AND DILUTED			246,101,376				224,253,653				237,227,080				216,467,166

 

 

 

The accompanying notes are an integral part of these financial statements

 

XSUNX, INC.

(A Development Stage Company)

STATEMENT OF SHAREHOLDERS’ DEFICIT

 

																										Deficit
																		Additional				Stock Options/				Accumulated during the
		Preferred Stock								Common Stock								Paid-in				Warrants				Development				Total
Balance at September 30, 2011			—			$	—				224,998,637			$	25,638,369			$	5,238,213			$	3,635,079			$	(35,037,459	)		$	(525,798	)
Issuance of common stock for cash
(prices between $0.015 and $0.0165 per share) (unaudited)			—				—				3,181,819				50,000				—				—				—				50,000
Shares issued for conversion of debt at fair value (unaudited)			—				—				7,000,000				420,000				—				—				—				420,000
Issuance of common stock for services at fair value (unaudited)			—				—				9,089,766				199,820				—				—				—				199,820
Issurance of common stock for settlement of debt (unaudited)			—				—				17,877,833				536,335				—				—				—				536,335
Issurance of common stock for prepaid expenses (unaudited)			—				—				8,122,167				243,665				—				—				—				243,665
Issuance of common stock for commitment fees (unaudited)			—				—				1,500,000				45,000				—				—				—				45,000
Issurance of common stock through a cashless exercise (unaudited)			—				—				5,860,791				—				—				—				—				—
Stock compensation expense (unaudited)			—				—				—				—				—				129,834				—				129,834
Contributed capital (unaudited)			—				—				—				—				33,635				—				—				33,635
Contributed services (unaudited)			—				—				—				—				60,000				—				—				60,000
Net loss for the nine months ended June 30, 2012 (unaudited)			—				—				—				—				—				—				(1,355,064	)			(1,355,064	)
Balance at June 30, 2012			—			$	—				277,631,013			$	27,133,189			$	5,331,848			$	3,764,913			$	(36,392,523	)		$	(162,573	)

 

 

 

 

 

The accompanying notes are an integral part of these financial statements

XSUNX, INC.

(A Development Stage Company)

STATEMENTS OF CASH FLOWS

(Unaudited)

 

										February 25,1997
		Nine Months Ended								through
		June 30, 2012				June 30, 2011				June 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss		$	(1,355,064	)		$	(812,582	)		$	(36,392,522	)
Adjustment to reconcile net loss to net cash
used in operating activities
Depreciation & amortization			30,006				29,098				717,832
Common stock issued for services and interest			34,351				—				2,030,985
Stock option and warrant expense			129,834				142,292				4,039,103
Beneficial conversion and commitment fees			45,000				—				5,730,573
Asset impairment			—				—				7,285,120
Write down of inventory asset			—				—				1,177,000
Gain on settlement of debt			—				(179,580	)			(466,961	)
(Gain)/Loss on sale of asset			—				(17,000	)			(16,423	)
Contributed  capital and  services			93,635				—				93,635
Settlement of lease			—				—				59,784
Loss on conversion and settlement of debt			496,874				—				496,874
Change in derivative liability			(68,184	)			—				(68,184	)
Amortization of discount on convertible promissory notes			146,129				—				146,129
Change in Assets and Liabilities:
(Increase) Decrease in:
Prepaid expenses			(48,467	)			10,348				(57,671	)
Inventory held for sale			—				—				(1,417,000	)
Other receivable			—				2,500				—
Other assets			(2,500	)			—				(5,700	)
Increase (Decrease) in:
Accounts payable			252,443				(101,063	)			2,622,543
Accrued expenses			47,903				37,248				163,013
NET CASH USED IN OPERATING ACTIVITIES			(198,040	)			(888,739	)			(13,861,870	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of manufacturing equipment and facilities in process			(21,830	)			—				(5,928,434	)
Payments on note receivable			—				—				(1,500,000	)
Proceeds from sale of assets			—				17,000				261,100
Receipts on note receivable			—				—				1,500,000
Payment for leasehold improvements			(23,511	)			—				(23,511	)
Purchase of marketable prototype			—				—				(1,780,396	)
Purchase of fixed assets			(52,124	)			(6,053	)			(650,096	)
NET CASH USED BY INVESTING ACTIVITIES			(97,465	)			10,947				(8,121,337	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from warrant conversion			—				—				3,306,250
Proceeds from convertible promissory notes			235,500				—				6,085,500
Proceeds for issuance of common stock, net			50,000				825,000				12,648,028
NET CASH PROVIDED BY FINANCING ACTIVITIES			285,500				825,000				22,039,778
NET INCREASE (DECREASE) IN CASH			(10,005	)			(52,792	)			56,571
CASH, BEGINNING OF PERIOD			66,576				200,422				—
CASH, END OF PERIOD		$	56,571			$	147,630			$	56,571
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid		$	764			$	131			$	120,775
Taxes paid		$	—			$	—			$	—
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
During the nine months ended June 30, 2012, in exchange for the note of $456,920 plus accrued interest of $98,645 that was due at September 1, 2011,
the Company issued 7,000,000 restricted shares of common stock as payment for the reduction of $205,565 of prinicipal balance and accrued interest
under the note, and issued a new unsecured promissory exchange note in the amount of $350,000. Also, the Company issued 6,139,688 shares of common
stock for the conversion of $95,500 promissory notes, which included interest of $3,820. Additionaly the Company issued 5,860,791 shares of restricted common
stock as a result of the a cashless exercise of stock purchase warrants during the nine months ended June 30, 2012.

 

The accompanying notes are an integral part of these financial statements

XSUNX, INC.

(A Development Stage Company)

Notes to Financial Statements – (Unaudited)

June 30, 2012

 

1.    BASIS OF PRESENTATION

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the nine months ended June 30, 2012 are not necessarily indicative of the results that may be expected for the year ending September 30, 2012. For further information refer to the financial statements and footnotes thereto included in the Company's Form 10-K for the year ended September 30, 2011.

 

Going Concern

The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company does not generate significant revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. The Company has obtained funds from its shareholders since its inception through the period ended June 30, 2012. Management believes the existing shareholders and the prospective new investors will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core of business.

 

2.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

This summary of significant accounting policies of XsunX, Inc. is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

 

Development Stage Activities and Operations

The Company has been in its initial stages of formation and for the nine months ended June 30, 2012, and had no revenues. A development stage activity as one in which all efforts are devoted substantially to establishing a new business and even if planned principal operations have commenced, revenues are insignificant.

 

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, and the fair value of stock options. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

For purposes of the statements of cash flows, cash and cash equivalents include cash in banks and money markets with an original maturity of three months or less.

 

Fair Value of Financial Instruments

The Company’s financial instruments, including cash and cash equivalents, accounts payable and accrued liabilities are carried at cost, which approximates their fair value, due to the relatively short maturity of these instruments. As of June 30, 2012, and September 30, 2011, the Company’s notes payable have stated borrowing rates that are consistent with those currently available to the Company and, accordingly, the Company believes the carrying value of these debt instruments approximates their fair value.

XSUNX, INC.

(A Development Stage Company)

Notes to Financial Statements – (Unaudited)

June 30, 2012

 

2.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Loss Per Share Calculations

Loss per Share is the calculation of basic earnings per share and diluted earnings per share. Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator or is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the nine months ended June 30, 2012 as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss.

 

Revenue Recognition

The Company recognizes revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. To date the Company has had minimal revenue and is still in the development stage.

 

Stock-Based Compensation

Share-based Payment applies to transactions in which an entity exchanges its equity instruments for goods or services and also applies to liabilities an entity may incur for goods or services that are to follow a fair value of those equity instruments. We are required to follow a fair value approach using an option-pricing model, such as the Black Scholes option valuation model, at the date of a stock option grant. The deferred compensation calculated under the fair value method would then be amortized over the respective vesting period of the stock option. This has not had a material impact on our results of operations.

Fair Value of Financial Instruments

Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of June 30, 2012, the balances reported for cash, prepaid expenses, accounts payable, accrued expenses, and derivative liability approximate the fair value because of their short maturities.

 

We adopted ASC Topic 820 (originally issued as SFAS 157, “Fair Value Measurements”) as of January 1, 2008 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

 

·

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

·

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

·

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

XSUNX, INC.

(A Development Stage Company)

Notes to Financial Statements – (Unaudited)

June 30, 2012

 

2.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at June 30, 2012:

 

Fair Value of Financial Instruments

 

		Total				(Level 1)				(Level 2)				(Level 3)
Assets		$	—			$	—			$	—			$	—
Total assets measured at fair value		$	—			$	—			$	—			$	—
Liabilities
Derivative Liability		$	167,315			$	—			$	—			$	167,315
Convertible Debenture, net of discount			50,629				—				—				50,629
Total liabilities measured at fair value		$	217,944			$	—			$	—			$	217,944

 

Recently adopted accounting pronouncements

Management reviewed accounting pronouncements issued during the three months ended June 30, 2012, and no pronouncements were adopted during the period.

 

3.

CAPITAL STOCK

 

At June 30, 2012, the Company’s authorized stock consisted of 500,000,000 shares of common stock, with no par value. The Company is also authorized to issue 50,000,000 shares of preferred stock with a par value of $0.01 per share. The rights, preferences and privileges of the holders of the preferred stock will be determined by the Board of Directors prior to issuance of such shares.

 

During the nine months ended June 30, 2012, the Company issued 7,000,000 restricted shares of common stock as payment for the reduction of $205,565 of principal and accrued interest balance under a note originally issued by the Company in August 2009. As of the date of the transaction the fair value of the shares issued for the debt reduction was $420,000 resulting in a loss on conversion of $214,435. During the nine months ended June 30, 2012, the Company also accepted offers for the sale of 1,666,667 units composed of one share of restricted common stock and a five year warrant exercisable to purchase two shares of Common Stock at $0.015 per share for cash of $25,000; and 1,515,152 units composed of one share of restricted common stock and a five year warrant exercisable to purchase two shares of Common Stock at $0.0165 per share for cash of $25,000; a holder of two warrants in the amount of 2,500,000 each exercised all available warrants utilizing a cashless exercise provision resulting in the total net issuance of 2,580,646 shares of the Company’s restricted common stock; a holder of a warrant in the amount of 3,333,334 exercised all available warrants utilizing a cashless exercise provision resulting in the net issuance of 1,720,430 shares of the Company’s restricted common stock; a holder of a warrant in the amount of 3,030,303 exercised all available warrants utilizing a cashless exercise provision resulting in the net issuance of 1,559,715 shares of the Company’s restricted common stock; 400,000 shares of the Company’s restricted common stock were issued for accounts payable of $17,000 with a fair value of $14,000 and recognized a gain of $3,000; 550,078 shares of the Company’s restricted common stock were issued for services at fair value of $19,000; 2,000,000 shares of the Company’s restricted common stock were issued to a scientific consultant for $7,500 in services related to a special assembly project and 12 months of consulting services valued at $60,000; the holder of two unsecured 8% convertible notes issued by the Company on October 27 and December 7, 2011 convert the total accrued principal and interest for each note in the amount of $55,120 and $44,200 respectively. Upon conversion the Company issued 3,245,639 and 2,894,049 shares respectively of common voting stock to the holder. The above shares were issued in a transactions exempt from registration pursuant to Section 4(2) of the Securities Act. Also, during the period certain employees forgave their salary, which has been reflected as contributed services in the financial statements.

 

XSUNX, INC.

(A Development Stage Company)

Notes to Financial Statements – (Unaudited)

June 30, 2012

 

3.

CAPITAL STOCK (Continued)

 

Also, during the nine months ended June 30, 2012, the Company issued an aggregate of 27,500,000 shares of the Company’s common stock, no par value per share, to Ironridge Global IV, Ltd., of which 26,000,000 shares were for settlement of accounts payable of $494,561 with a fair value of $780,000, and the Company recognized a loss of $285,439. Also, 1,500,000 shares of common stock with a fair value of $45,000 were retained by Ironridge Global IV, Ltd. The issuance is exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 3(a)(10) thereof, as an issuance of securities in exchange for bona fide outstanding claims, where the terms and conditions of such issuance are approved by a court after a hearing upon the fairness of such terms and conditions.

  

During the nine months ended June 30, 2011, pursuant to an S-1 Registration Statement declared effective by the SEC on June 30, 2010, and a Post-Effective Amendment No.1 registration declared effective by the Securities and Exchange Commission on April 4, 2011 the Company sold to Lincoln Park Capital Group, LLC (LPC) a total of approximately 6,853,376 shares for a total investment of $575,000. These shares were sold at various pricing between $0.08 and $0.0888 per share. An additional 159,720 of the remaining pool of 1,236,112 commitment shares were issued on a pro rata basis to LPC as LPC has purchased additional shares pursuant to the effective S-1 Registration Statement. The agreement with Lincoln Park has expired and the registration statement is currently not available for use for sales to Lincoln Park.

 

Also, during the nine months ended June 30, 2011, the Company also issued 5,000,000 units composed of one share of restricted common stock and a five year warrant exercisable to purchase two shares of Common Stock at $0.04 per share for cash of $200,000; 1,250,000 shares of restricted common stock at a price of $0.04 per share for cash of $50,000; a holder of warrants exercised all available 5,000,000 warrants utilizing a cashless exercise provision resulting in the net issuance of 2,680,204 shares of the Company’s restricted common stock. The above shares were issued in a transactions exempt from registration pursuant to Section 4(2) of the Securities Act.

 

4.

STOCK OPTION AND WARRANTS

 

The Company adopted a Stock Option Plan for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of Options for Twenty Million (20,000,000) shares of Common Stock. Options granted under the Plan may be either Incentive Options or Nonqualified Options and shall be administered by the Company's Board of Directors ("Board"). Each Option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective Option agreements may provide. Notwithstanding any other provision of the Plan or of any Option agreement, each Option shall expire on the date specified in the Option agreement.

 

Risk free interest rate	1.14% to 2.77%
Stock volatility factor	90.56% to 104.73%
Weighted average expected option life	5 years
Expected dividend yield	None

 

A summary of the Company’s stock option activity and related information follows:

		6/30/2012
						Weighted
		Number				average
		of				exercise
		Options				price
Outstanding, beginning of the period			20,950,000			$	0.180
Granted			1,500,000				0.045
Exercised			—				—
Expired			(14,350,000	)			0.140
Outstanding, end of the period			8,100,000			$	0.200
Exercisable at the end of the period			6,600,000			$	0.270
Weighted average fair value of
options granted during the period						$	0.045

XSUNX, INC.

(A Development Stage Company)

Notes to Financial Statements – (Unaudited)

June 30, 2012

 

4.

STOCK OPTION AND WARRANTS (Continued)

 

The weighted average remaining contractual life of options outstanding issued under the plan as of June 30, 2012 was as follows:

 

												Weighted
												Average
				Stock				Stock				Remaining
Exercisable				Options				Options				contractual
Prices				Outstanding				Exercisable				Life (years)
$	0.41				100,000				100,000				0.16
$	0.36				2,000,000				1,500,000				0.31
$	0.36				500,000				500,000				0.37
$	0.36				500,000				500,000				0.41
$	0.16				2,500,000				2,500,000				1.75
$	0.10				1,000,000				—				3.30
$	0.05				1,500,000				1,500,000				4.54
					8,100,000				6,600,000

 

 

Stock-based compensation expense recognized during the period is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. Stock-based compensation expense recognized in the financial statements of operations during the nine months ended June 30, 2012, included compensation expense for the stock-based payment awards granted prior to, but not yet vested, as of June 30, 2012 based on the grant date fair value estimated, and compensation expense for the stock-based payment awards granted subsequent to June 30, 2012, based on the grant date fair value estimated. We account for forfeitures as they occur. The stock-based compensation expense recognized in the statement of operations during the nine months ended June 30, 2012 and 2011 was $129,834 and $96,458, respectively.

 

Warrants

A summary of the Company’s warrants activity and related information follows:

		6/30/2012
						Weighted
		Number				average
		of				exercise
		Options				price
Outstanding, beginning of the period			8,583,332			$	0.61
Granted			6,363,637			$	0.02
Exercised			(11,363,637	)		$	0.02
Expired			(250,000	)		$	0.20
Outstanding, end of the period			3,333,332			$	0.63
Exercisable at the end of period			3,333,332			$	0.63
Weighted average fair value of
warrants granted during the period						$	0.02

 

XSUNX, INC.

(A Development Stage Company)

Notes to Financial Statements – (Unaudited)

June 30, 2012

 

4.

STOCK OPTION AND WARRANTS (Continued)

At June 30, 2012, the weighted average remaining contractual life of warrants outstanding:

												Weighted
												Average
												Remaining
Exercisable				Warrants				Warrants				Contractual
Prices				Outstanding				Exercisable				Life (years)
$	0.50				1,666,666				1,666,666				0.34
$	0.75				1,666,666				1,666,666				0.34
					3,333,332				3,333,332

5.

PROMISSORY NOTE

 

During the year ended September 30, 2009, the Company converted an account payable to a promissory note (the “Note”) in the amount of $456,920. On November 3, 2011, in exchange for the Note of $456,920 plus accrued interest of $98,645 that had become due at September 1, 2011, the Company issued 7,000,000 restricted shares of common stock with a fair value of $420,000 as payment for the reduction of $205,565 of principal balance and accrued interest under the Note, and incurred a loss on the conversion of the debt in the amount of $214,435. Also, as part of the payment of the note, the Company issued a new unsecured promissory exchange note (the “Exchange Note”) in the amount of $350,000. The note bears interest at 10% per annum and matures on September 30, 2012.

 

6.

CONVERTIBLE PROMISSORY NOTES

 

During the nine months ended June 30, 2012, the Company entered into six Securities Purchase Agreements (the "Purchase Agreements") each providing for the sale by the Company of 8% unsecured Convertible Notes (“the Notes”) in the principal amounts of $53,000, $42,500, $32,500, $37,500, $37,500, and $32,500 for an aggregate total of $235,500. During the nine months ended June 30, 2012 the holder convert the $53,000 Note plus $2,120 in accrued interest, and the $42,500 Note plus $1,700 in accrued interest. Upon conversion the Company issued 3,245,639 and 2,894,049 shares respectively of common voting stock to the holder. The remaining Notes mature on October 19, 2012, December 19, 2012, January 30, 2013, and March 6, 2013. The Company has the right to redeem a portion or all amounts outstanding under the any Note prior to one hundred and eighty one days from issuance of the Note under a variable redemption rate premium. After one hundred and eighty days the holder may convert into shares of common stock at a variable conversion price of 60% multiplied by the market price of the average lowest five (5) trading prices for the common stock during the ten (10) trading days prior to the conversion date.

 

ASC Topic 815 provides guidance applicable to convertible debt issued by the Company in instances where the number into which the debt can be converted is not fixed. For example, when a convertible debt converts at a discount to market based on the stock price on the date of conversion, ASC Topic 815 requires that the embedded conversion option of the convertible debt be bifurcated from the host contract and recorded at their fair value. In accounting for derivatives under accounting standards, the Company recorded a liability of $167,315 representing the estimated present value of the conversion feature considering the historic volatility of the Company’s stock, and a discount of $235,500 representing the imputed interest associated with the embedded derivative. The discount is amortized over the life of the convertible debts, which resulted in the recognition of $146,129 in interest expense for the nine months ended June 30, 2012, and the derivative liability is adjusted periodically according to stock price fluctuations. At the time of conversion, any remaining derivative liability will be charged to additional paid-in capital. For purpose of determining the fair market value of the derivative liability, the Company used Black Scholes option valuation model. The significant assumptions used in the Black Scholes valuation of the derivative are as follows:

 

Stock price on the valuation dates		$	0.03
Conversion price for the debt		$	0.0018
Dividend yield			0.00	%
Months to Maturity			4 to 9
Risk free rate			Between 0.11% and 0.21%
Expected volatility			Between 88.46% and 160.70%

 

The value of the derivative liability at June 30, 2012 was $167,315.

 

XSUNX, INC.

(A Development Stage Company)

Notes to Financial Statements – (Unaudited)

June 30, 2012

 

7.

SETTLEMENT OF CLAIMS

 

On June 27, 2012, XsunX, Inc. (the “Company”) issued an aggregate of 27,500,000 shares of the Company’s common stock, no par value per share (the “Initial Shares”), to Ironridge Global IV, Ltd. (“Ironridge”), in settlement of approximate $494,561 in accounts payable of the Company (the “Accounts Payable”). The transaction thereby substantially reduced the Company’s liabilities, including its outstanding accounts payable balance associated with the assembly of the Company’s CIGSolar™ thermal evaporation technology.

 

The Initial Shares were issued pursuant to an Order for Approval of Stipulation for Settlement of Claims (the “Order”) between the Company and Ironridge, in settlement of the bona fide accounts payable of the Company, which had been purchased by Ironridge from certain creditors of the Company, in an amount equal to the Accounts Payable, plus fees and costs. The Order was entered by the Superior Court of the State of California, County of Los Angeles, Central District on June 26, 2012.

 

The Order also provides for an adjustment in the total number of shares which may be issuable to Ironridge based on a calculation period for the transaction, defined as that number of consecutive trading days following the date on which the Initial Shares were issued (the “Issuance Date”) required for the aggregate trading volume of the Common Stock, as reported by Bloomberg LP, to exceed $2.5 million (the “Calculation Period”). Pursuant to the Order, Ironridge will retain 1,500,000 shares of the Company’s Common Stock, plus that number of shares (the “Final Amount”) with an aggregate value equal to (a) the sum of the Accounts Payable plus 8% agent fee and reasonable attorney fees through the end of the Calculation Period, (b) divided by 80% of the following: the volume weighted average price (“VWAP”) of the Common Stock over the length of the Calculation Period, as reported by Bloomberg, not to exceed the arithmetic average of the individual daily VWAPs of any five trading days during the Calculation Period. The Order further provides that during the Calculation Period, or if at any time during such period a daily VWAP is below 80% of the closing price on the day before the issuance date, or if the Initial Shares are less than ay reasonable Final Amount, the Company will issue additional shares (each, an “Additional Issuance”), subject to a 9.99% beneficial ownership limitation specified in the Order. The Company has reserved from its duly authorized capital stock twice the number of shares that could be issued pursuant to the Order based on the most recent daily VWAP at the time of the Order and will, if necessary, increase the number of shares reserved based on the lowest daily VWAP during the Calculation Period. At the end of the Calculation Period, (a) if the sum of the Initial Shares and any Additional Issuance is less than the Final Amount, the Company shall issue additional shares to Ironridge, up to the Final Amount, and (b) if the sum of the Initial Shares and any Additional Issuance is greater than the Final Amount, Ironridge shall promptly return any remaining shares to the Company and its transfer agent for cancellation.

 

In connection with the transaction, Ironridge represented that it does not hold any short position in the company’s stock, and warranted that it would not to engage in or affect, directly or indirectly, any short sale of the common stock.

 

The issuance is exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 3(a)(10) thereof, as an issuance of securities in exchange for bona fide outstanding claims, where the terms and conditions of such issuance are approved by a court after a hearing upon the fairness of such terms and conditions.

 

8.

RELATED PARTY TRANSACTIONS

 

During the period ended June 30, 2012, the Company’s Chief Executive Officer had unpaid salary in the amount of $33,635, which has been reflected as capital contributed in accordance with SAB 55.

 

9.

SUBSEQUENT EVENTS

 

The following are items management has evaluated as subsequent events pursuant to the requirement of ASC Topic 855.

 

 

XSUNX, INC.

(A Development Stage Company)

Notes to Financial Statements – (Unaudited)

June 30, 2012

 

9.

SUBSEQUENT EVENTS (Continued)

 

Between July 23 and July 30, 2012, the holder of an unsecured 8% convertible note issued by the Company on January 17, 2012 elected to convert the total principal balance and accrued interest in the amount of $33,800. Upon conversion the Company issued a total of 1,676,211 shares of common voting stock to the holder. On July 11, 2012 the Company issued 500,000 shares of restricted common voting stock to its landlord as partial rent payment for lease of additional commercial and office space.

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

CAUTIONARY AND FORWARD LOOKING STATEMENTS

 

In addition to statements of historical fact, this Quarterly Report on Form 10-Q contains forward-looking statements. The presentation of future aspects of XsunX, Inc. ("XsunX", the "Company" or "issuer") found in these statements is subject to a number of risks and uncertainties that could cause actual results to differ materially from those reflected in such statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. Without limiting the generality of the foregoing, words such as "may", "will", "expect", "believe", "anticipate", "intend", or "could" or the negative variations thereof or comparable terminology are intended to identify forward-looking statements. Our actual results could differ materially from those anticipated by these forward-looking statements as a result of many factors, including those discussed under “Item 1A: Risk Factors” in the Company’s Annual Report on Form 10-K and elsewhere in this Quarterly Report on Form 10-Q.

 

These forward-looking statements are subject to numerous assumptions, risks and uncertainties that may cause XsunX's actual results to be materially different from any future results expressed or implied by XsunX in those statements. Important facts that could prevent XsunX from achieving any stated goals include, but are not limited to, the following:

 

Some of these risks might include, but are not limited to, the following:

 

(a) volatility or decline of the Company's stock price;

 

(b) potential fluctuation in quarterly results;

 

(c) failure of the Company to earn revenues or profits;

 

(d) inadequate capital to continue or expand its business, inability to raise additional capital or financing to implement its business plans;

 

(e) failure to commercialize its technology or to make sales;

 

(f) rapid and significant changes in markets;

 

(g) litigation with or legal claims and allegations by outside parties;

 

(h) insufficient revenues to cover operating costs.

 

There is no assurance that the Company will be profitable, the Company may not be able to successfully develop, manage or market its products and services, the Company may not be able to attract or retain qualified executives and technology personnel, the Company's products and services may become obsolete, government regulation may hinder the Company's business, additional dilution in outstanding stock ownership may be incurred due to the issuance of more shares, warrants and stock options, or the exercise of warrants and stock options, and other risks inherent in the Company's businesses.

 

The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Readers should carefully review the factors described in other documents the Company files from time to time with the Securities and Exchange Commission, including the Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K filed by the Company and any Current Reports on Form 8-K filed by the Company.

 

Management believes the summary data presented herein is a fair presentation of the Company's results of operations for the periods presented. Due to the Company's change in primary business focus and new business opportunities these historical results may not necessarily be indicative of results to be expected for any future period. As such, future results of the Company may differ significantly from previous periods.

 

Business Overview

 

XsunX, Inc. is developing and has begun to market a hybrid manufacturing solution to produce high performance

 

 

Copper Indium Gallium (di) Selenide (CIGS) thin film solar cells. Our patent pending processing technology, which we call CIGSolar™, focuses on the mass production of individual thin-film CIGS solar cells that match silicon solar cell dimensions and can be offered as a non-toxic, high-efficiency and lowest-cost alternative to the use of silicon solar cells. We intend to offer licenses for the use of the CIGSolar™ process technology thereby generating revenue streams through licensing fees and manufacturing royalties for the use of the technology.

 

Our efforts have been focused on the development and customization of a series of specialized processing tools that when combined provide a turn-key high-throughput manufacturing system to produce CIGS solar cells.

 

Core attributes to our process method are the use of small area thermal co-evaporation techniques coupled with state-of-the-art sputter deposition technologies to improve manufacturing output, increase cell efficiency, production yields, and lower the costs for the production of high efficiency CIGS cells.

 

There are five (5) core process tools that when combined will produce 156mm format (about 6” square) solar cells. We believe that it will be the ability of our system to minimize processing defects while maintaining exceptional per hour production rates that will provide superior commercial opportunities. CIGSolar™ cells will be manufactured on stainless steel squares sized to match silicon solar cells currently used in nearly 75% of all solar modules manufactured today.

 

This innovative approach bridges the gap between inexpensive thin-film and costly high efficiency silicon wafer technologies to produce a new breed of solar cell combining what we believe are the best attributes of each technology. The mass production of individual, high performance CIGS solar cells – like solar building blocks – we believe will allow solar power to finally compete effectively against other sources of electrical energy.

 

RESULTS OF OPERATIONS FOR THE NINE-MONTH PERIOD ENDED JUNE 30, 2012 COMPARED TO THE SAME PERIOD IN 2011

 

Revenue:

 

The Company generated no revenues for the periods ended June 30, 2012 and 2011 respectively. Additionally, there was no associated cost of sales. The Company to date has had minimal revenue and cost of sales, and is still in the development stage.

 

Selling, General and Administrative Expenses:

 

Selling, general and administrative expenses for the nine month period ending June 30, 2012 were $571,162 as compared to $723,467 during the same period in 2011. The decrease of $(152,305) was related primarily to a general reduction to salaries and operating expenses under the Company’s re-focused plan of operations for the development of a new cross-industry thin film solar manufacturing technology. We anticipate that expenditures associated with the development and sales of our thin-film solar manufacturing technologies will increase SG&A expenditures in the future. However, we plan to offer our technology as a licensable process to existing solar product manufacturers which we anticipate will mitigate future expenditures that would normally be associated with our need to establish direct large scale manufacturing capabilities and the associated facility infrastructure.

 

Research and Development:

 

Research and development for the nine month period ended June 30, 2012 were $95,476 as compared to $222,029 during the same period in 2011. The decrease of $(126,553) was primarily due to a reduction in salaries and research related efforts used in the period on the development of our new cross-industry thin film solar manufacturing technology CIGSolar™. During the period we continued to focus efforts to build a full sized multi-chamber CIGSolar™ processing system for use in continued process improvement, marketing efforts, and future systems sales support. We anticipate that future R&D expense will increase as we establish each of the various system capabilities within our own facilities for use in continued process improvement, marketing efforts, and systems support.

 

Net Loss:

 

The net loss for the nine months ended June 30, 2012 was $(1,355,064) as compared to a net loss of $(812,582) for the same period 2011. The increased net loss of $(542,482) includes the operating expense changes discussed above, and the net change in other expenses related to conversion of debt of $496,874, and non-cash expense of $908 for depreciation expense. The Company anticipates the trend of losses to continue in future quarters until the Company can recognize sales of significance of which there is no assurance.

 

LIQUIDITY AND CAPITAL RESOURCES

 

As of June 30, 2012, we had a working capital deficit of $(360,775) as compared to $(654,041) at September 30, 2011. This increase in working capital deficit of $(293,266) was due primarily to an increase in prepaid expenses, convertible promissory notes and derivative liability.

 

During the nine months ended June 30, 2012, the Company used $(198,040) of cash for operating activities, as compared to cash used of $(888,739) for the same period 2011. The decrease in cash used of $(690,699) for operating activities was primarily due to an increase in prepaid expenses, accounts payable, accrued expenses, and to a general reduction to salaries, staffing, and operating expenses under the Company’s re-focused plan of operations for the development of a new CIGSolar™ thin film solar manufacturing technology.

 

Cash provided by investing activities for the nine months ended June 30, 2012 was $(97,465), as compared to cash provided of $10,947 for the same period 2011. The net increase of cash used in investing activities was primarily due to an increase in the purchase of equipment and components, and leasehold improvements to the new facility, compared to the sale of assets in the prior period.

 

Cash provided by financing activities for the nine months ended June 30, 2012 was $285,500, as compared to $825,000 for the same period 2011. Our capital needs have primarily been met from the proceeds of private placements and the sale of notes, as we are currently in the development stage and had no revenues.

 

Our financial statements as of June 30, 2012 have been prepared under the assumption that we will continue as a going concern from inception (February 25, 1997) through June 30, 2012. Our independent registered public accounting firm has issued their report dated December 29, 2011, that included an explanatory paragraph expressing substantial doubt in our ability to continue as a going concern without additional capital becoming available. Our ability to continue as a going concern ultimately is dependent on our ability to generate a profit which is dependent upon our ability to obtain additional equity or debt financing, attain further operating efficiencies and, ultimately, to achieve profitable operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

For the nine months ended June 30, 2012, the Company's capital needs have been met from the use of working capital provided by the proceeds of (i) the Company’s working capital and (ii) the sale of convertible debt proceeds totaling $235,500 and (iii) the sale of common stock totaling $50,000.

 

DEVELOPMENT STAGE COMPANY

 

The Company is currently engaged in efforts to develop a cross-industry thin film solar manufacturing concept that we believe provides an opportunity for XsunX to establish a competitive advantage within the solar industry, and as of the period ended June 30, 2012, did not have any significant revenues. The transition to revenue recognition may exceed cash generated from operations in the current and future periods. We have in the past experienced substantial losses and negative cash flow from operations and have required financing, including equity and debt financing, in order to pursue the commercialization of products based on our technologies. We expect that we will continue to need significant financing to operate our business. If additional financing is not available or not available on terms acceptable to us, our ability to fund our operations, maintain our research and development efforts necessary to complete the development of marketable products or otherwise respond to competitive pressures may be significantly impaired. We could also be forced to curtail our business operations, reduce our investments, decrease or eliminate capital expenditures and delay the execution of our business plan which would have a material adverse affect on our business.

 

While we have been able to raise capital in a series of equity and debt offerings in the past there can be no assurances that we will be able to obtain such additional financing, on terms acceptable to us and at the times required, or at all.

 

Irrespective of whether the Company's cash assets prove to be inadequate to meet the Company's operational needs, the Company might seek to compensate providers of services by issuances of stock in lieu of cash.

 

OFF-BALANCE SHEET ARRANGEMENTS

 

We do not have any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, results of operations, liquidity or capital expenditures.

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

We do not have any market risk sensitive instruments. Since all operations are in U.S. dollar denominated accounts, we do not have foreign currency risk. Our operating costs are reported in U.S. dollars.

 

The Company does not invest in term financial products or instruments or derivatives involving risk other than money market accounts, which fluctuate with interest rates at market.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer, principal financial officer, and principal operating officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

 

As required by SEC Rule 15d-15(e), our management carried out an evaluation, under the supervision and with the participation of our principal executive officer, principal financial officer, and principal operating officer, of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our principal executive officer, principal financial officer, and principal accounting officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.

 

Changes in Internal Control over Financial Reporting

 

There have not been any changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the nine months ended June 30, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

In the ordinary conduct of our business, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results. However, in the period ended June 30, 2012 we did elect to settle the following claim;

 

On June 27, 2012, the Company issued an aggregate of 27,500,000 shares of the Company’s common stock, no par value per share, to Ironridge Global IV, Ltd., in settlement of approximate $494,561 in accounts payable of the Company. The transaction thereby substantially reduced the Company’s liabilities, including its outstanding accounts payable balance associated with the assembly of the Company’s CIGSolar™ thermal evaporation technology. The shares were issued pursuant to an Order for Approval of Stipulation for Settlement of Claims between the Company and Ironridge, in settlement of the bona fide accounts payable of the Company, which had been purchased by Ironridge from certain creditors of the Company, in an amount equal to the Accounts Payable, plus fees and costs. Please see (June 27, 2012 Ironridge Global IV, Ltd. under Item 2. Unregistered Sales of Equity Securities and Use of Proceeds) below for a detailed description of the transaction.

 

Item 1A. Risk Factors

 

There are no material changes from the risk factors previously disclosed in the Registrant’s Form 10-K filed on December 29, 2011.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

On November 3, 2011, in exchange for promissory note (the “Note”) of $456,920 plus accrued interest of $98,645 that had become due at September 1, 2011, the Company issued 7,000,000 restricted shares of common stock as payment for the reduction of $205,565 of principal and accrued interest balance under the Note, and exchanged the Note for and issued a new unsecured promissory exchange note (the “Exchange Note”) in the amount of $350,000.

 

In February 2012 the Company accepted an offer for the sale of 1,666,667 units composed of one share of restricted common stock and a five year warrant exercisable to purchase two shares of Common Stock at $0.015 per share for cash of $25,000. In March 2012 the Company accepted an offer for the sale of 1,515,152 units composed of one share of restricted common stock and a five year warrant exercisable to purchase two shares of Common Stock at $0.0165 per share for cash of $25,000. Between February and April 2012 the Company issued 950,078 shares of the Company’s restricted common stock to two services providers for services at fair value of $36,000. In May 2012 2,000,000 shares of the Company’s restricted common stock were issued to a scientific consultant for $7,500 in services related to a special assembly project and 12 months of consulting services valued at $60,000. The above shares were issued in a transactions exempt from registration pursuant to Section 4(2) of the Securities Act.

 

During the nine months ended June 30, 2012, the Company entered into Securities Purchase Agreements (the "Purchase Agreements") each providing for the sale by the Company of 8% unsecured Convertible Notes (“the Notes”) in the principal amounts of $53,000, $42,500, $32,500, $37,500, $37,500, and $32,500 for an aggregate total of $235,500. During the nine months ended June 30, 2012 the holder convert the $53,000 Note plus $2,120 in accrued interest, and the $42,500 Note plus $1,700 in accrued interest. Upon conversion the Company issued 3,245,639 and 2,894,049 shares respectively of common voting stock to the holder. The remaining Notes mature on October 19, 2012, December 19, 2012, January 30, 2013, and March 6, 2013. The Company has the right to redeem a portion or all amounts outstanding under the any Note prior to one hundred and eighty one days from issuance of the Note under a variable redemption rate premium. After one hundred and eighty days the holder may convert into shares of common stock at a variable conversion price of 60% multiplied by the market price of the average lowest five (5) trading prices for the common stock during the ten (10) trading days prior to the conversion date.

 

On June 27, 2012, XsunX, Inc. (the “Company”) issued an aggregate of 27,500,000 shares of the Company’s common stock, no par value per share (the “Initial Shares”), to Ironridge Global IV, Ltd. (“Ironridge”), in settlement of approximate $494,561 in accounts payable of the Company (the “Accounts Payable”). The transaction thereby substantially reduced the Company’s liabilities, including its outstanding accounts payable balance associated with the assembly of the Company’s CIGSolar™ thermal evaporation technology.

 

 

The Initial Shares were issued pursuant to an Order for Approval of Stipulation for Settlement of Claims (the “Order”) between the Company and Ironridge, in settlement of the bona fide accounts payable of the Company, which had been purchased by Ironridge from certain creditors of the Company, in an amount equal to the Accounts Payable, plus fees and costs. The Order was entered by the Superior Court of the State of California, County of Los Angeles, Central District on June 26, 2012.

 

The Order also provides for an adjustment in the total number of shares which may be issuable to Ironridge based on a calculation period for the transaction, defined as that number of consecutive trading days following the date on which the Initial Shares were issued (the “Issuance Date”) required for the aggregate trading volume of the Common Stock, as reported by Bloomberg LP, to exceed $2.5 million (the “Calculation Period”). Pursuant to the Order, Ironridge will retain 1,500,000 shares of the Company’s Common Stock, plus that number of shares (the “Final Amount”) with an aggregate value equal to (a) the sum of the Accounts Payable plus 8% agent fee and reasonable attorney fees through the end of the Calculation Period, (b) divided by 80% of the following: the volume weighted average price (“VWAP”) of the Common Stock over the length of the Calculation Period, as reported by Bloomberg, not to exceed the arithmetic average of the individual daily VWAPs of any five trading days during the Calculation Period. The Order further provides that during the Calculation Period, or if at any time during such period a daily VWAP is below 80% of the closing price on the day before the issuance date, or if the Initial Shares are less than any reasonable Final Amount, the Company will issue additional shares (each, an “Additional Issuance”), subject to a 9.99% beneficial ownership limitation specified in the Order. The Company has reserved from its duly authorized capital stock twice the number of shares that could be issued pursuant to the Order based on the most recent daily VWAP at the time of the Order and will, if necessary, increase the number of shares reserved based on the lowest daily VWAP during the Calculation Period. At the end of the Calculation Period, (a) if the sum of the Initial Shares and any Additional Issuance is less than the Final Amount, the Company shall issue additional shares to Ironridge, up to the Final Amount, and (b) if the sum of the Initial Shares and any Additional Issuance is greater than the Final Amount, Ironridge shall promptly return any remaining shares to the Company and its transfer agent for cancellation.

 

In connection with the transaction, Ironridge represented that it does not hold any short position in the company’s stock, and warranted that it would not to engage in or affect, directly or indirectly, any short sale of the common stock.

 

The issuance is exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 3(a)(10) thereof, as an issuance of securities in exchange for bona fide outstanding claims, where the terms and conditions of such issuance are approved by a court after a hearing upon the fairness of such terms and conditions.

 

Use of Proceeds from the Sale of Securities

 

The proceeds from the above sales of securities were and are being used primarily to fund efforts by the Company to develop marketable technologies for the manufacture of thin film solar technologies, and in the day-to-day operations of the Company and to pay the accrued liabilities associated with these operations.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. (Removed and Reserved)

 

Item 5. Other information

 

Between July 23 and July 30, 2012, the holder of an unsecured 8% convertible note issued by the Company on January 17, 2012 elected to convert the total principal balance and accrued interest in the amount of $33,800. Upon conversion the Company issued a total of 1,676,211 shares of common voting stock to the holder.

 

On July 11, 2012 the Company issued 500,000 shares of restricted common voting stock to its landlord as partial rent payment for lease of additional commercial and office space.

 

 

 

Item 6. Exhibits

 

3.1		Articles of Incorporation(1)
3.2		Bylaws(2)
10.1		XsunX Plan of Reorganization and Asset Purchase Agreement, dated September 23, 2003.(3)
10.2		XsunX 2007 Stock Option Plan, dated January 5, 2007.(4)
10.3		Common Stock Purchase Agreement dated as of March 30, 2010, by and between the Company and Lincoln Park Capital Fund, LLC. (5)
10.4		Registration Rights Agreement dated as of March 30, 2010, by and between the Company and Lincoln Park Capital Fund, LLC. (5)
10.5		Form S-1 and S-1/A related to the filing of a registration statement by the Company (6)(7)
10.6		Form S-1/A related to the filing of a Post-Effective Amendment No.1 registration statement by the Company. (8)
10.9		Form of Exchange Agreement and Exchange Note used in connection with the exchange, partial repayment, and extension to a promissory note that had become due September 1, 2011. (9)
10.10		Form of Securities Purchase Agreement and Convertible Promissory Note used in connection with the sale of convertible promissory notes in the aggregate amount of $273,000. (9)
10.11		Form of Consulting Agreement used in connection with the retention of a scientific advisor and the issuance of 2,000,000 shares of common stock. (11)
10.12		Form of Stock Option Agreement used by the Company to grant 500,000 common stock purchase options to each of three unaffiliated members of the Board of Directors on January 11, 2012. (10)
31.1		Sarbanes-Oxley Certification (10)
32.1		Sarbanes-Oxley Certification (10)
(1)		Incorporated by reference to Registration Statement Form 10SB12G #000-29621dated February 18, 2000 and by reference to exhibits included with the Company’s prior Report on Form 8-K/A filed with the Securities and Exchange Commission dated October 29, 2003.
(2)		Incorporated by reference to Registration Statement Form 10SB12G #000-29621 filed with the Securities and Exchange Commission dated February 18, 2000.
(3)		Incorporated by reference to exhibits included with the Company’s Report on Form 8-K/A filed with the Securities and Exchange Commission dated October 29, 2003.
(4)		Incorporated by reference to exhibits included with the Company’s Report on Form 8-K filed with the Securities and Exchange Commission dated January 5, 2007.
(5)		Incorporated by reference to exhibits included with the Company’s Report on Form 8-K filed with the Securities and Exchange Commission dated April 1, 2010.
(6)		Incorporated by reference to exhibits included with the Company’s Report on Form S-1 filed with the Securities and Exchange Commission dated April 30, 2010.
(7)		Incorporated by reference to exhibits included with the Company’s Report on Form S-1/A filed with the Securities and Exchange Commission dated June 25, 2010.
(8)		Incorporated by reference to exhibits included with the Company’s Post-Effective Amendment No.1 Report on Form S-1/A filed with the Securities and Exchange Commission dated March 29, 2011.
(9)		Incorporated by reference to exhibits included with the Company’s Report on Form 10-K filed with the Securities and Exchange Commission dated December 29, 2011.
(10)		Incorporated by reference to exhibits included with the Company’s Report on Form 10-Q filed with the Securities and Exchange Commission dated February 13, 2012.
(11)		Provided herewith Incorporated by reference to exhibits included with the Company’s Report on Form 10-Q filed with the Securities and Exchange Commission dated August 14, 2012.

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	XSUNX, INC.
Dated: August 14, 2012	By:	/s/ Tom M. Djokovich
		Tom M. Djokovich, Principal Executive and Financial Officer